Skip to main content
Top
Published in: International Urology and Nephrology 3/2011

01-09-2011 | Urology – Original Paper

Urinary ultrasonography in screening incidental renal cell carcinoma: is it obligatory?

Authors: Ahmet Hakan Haliloglu, Omer Gulpinar, Eriz Ozden, Yasar Beduk

Published in: International Urology and Nephrology | Issue 3/2011

Login to get access

Abstract

Purpose

To analyze the rate of incidental renal carcinoma in patients with no upper urinary tract symptoms (UUTS) or hematuria depending on the sonography reports and medical records of the patients and to determine whether there is a need for routine US screening for RCC.

Materials and methods

We reviewed the reports of 18.686 consecutive urinary US examinations performed in our department between March 1995 and February 2008. A total of 18.203 urinary US examinations formed the study group. Patients with UUTS, patients with presumed diagnosis of or previously diagnosed renal masses, and patients with hematuria were excluded.

Results

There were 11,654 male and 6,549 female patients with a mean age of 55 years. Ultrasonography revealed incidental solid renal masses in 0.44% of the patients. Seven of the 81 patients with incidentally detected renal masses could not be followed up. Thirty-eight of the remaining 74 patients had masses that were proved to be benign with other imaging techniques. Thirty-six of the 74 patients with preoperative diagnosis of renal tumor underwent surgery, and the histopathological diagnosis was renal cell carcinoma in all patients. One patient expired in the postoperative 18th month due to the progression of the metastatic disease. The rest of the patients with malignant renal tumor are disease free and are still under follow-up.

Conclusion

The rate of incidental renal cancer in patients without UUTS is found to be 0.20%. We believe that scanning for incidental renal masses is not obligatory except for the patients with symptoms suggestive of renal carcinoma.
Literature
1.
go back to reference Malaeb BS, Martin DJ, Littooy FN et al (2005) The utility of screening renal ultrasonography: identifying renal cell carcinoma in an elderly asymptomatic population. BJU Int 95:977–981PubMedCrossRef Malaeb BS, Martin DJ, Littooy FN et al (2005) The utility of screening renal ultrasonography: identifying renal cell carcinoma in an elderly asymptomatic population. BJU Int 95:977–981PubMedCrossRef
2.
go back to reference Wünsch-Filho V (2002) Insights on diagnosis, prognosis and screening of renal cell carcinoma. Sao Paulo Med J 120:163–164PubMedCrossRef Wünsch-Filho V (2002) Insights on diagnosis, prognosis and screening of renal cell carcinoma. Sao Paulo Med J 120:163–164PubMedCrossRef
3.
go back to reference Aslaksen A, Halvorsen OJ, Göthlin JH (1990) Detection of renal and renal pelvic tumours with urography and ultrasonography. Eur J Radiol 11:54–58PubMedCrossRef Aslaksen A, Halvorsen OJ, Göthlin JH (1990) Detection of renal and renal pelvic tumours with urography and ultrasonography. Eur J Radiol 11:54–58PubMedCrossRef
4.
go back to reference McDonald MM, Swagerty D, Wetzel L (2006) Assessment of microscopic hematuria in adults. Am Fam Physician 73:1748–1754PubMed McDonald MM, Swagerty D, Wetzel L (2006) Assessment of microscopic hematuria in adults. Am Fam Physician 73:1748–1754PubMed
5.
go back to reference Heidenreich A, Ravery V (2004) Preoperative imaging in renal cell cancer. World J Urol 22:307–315PubMedCrossRef Heidenreich A, Ravery V (2004) Preoperative imaging in renal cell cancer. World J Urol 22:307–315PubMedCrossRef
6.
go back to reference Schlomer B, Figenshau RS, Yan Y, Venkatesh R, Bhayani SB (2006) Pathological features of renal neoplasms classified by size and symptomatology. J Urol 176:1317–1320PubMedCrossRef Schlomer B, Figenshau RS, Yan Y, Venkatesh R, Bhayani SB (2006) Pathological features of renal neoplasms classified by size and symptomatology. J Urol 176:1317–1320PubMedCrossRef
7.
go back to reference Frank I, Blute ML, Cheville JC et al (2003) Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 170:2217–2220PubMedCrossRef Frank I, Blute ML, Cheville JC et al (2003) Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 170:2217–2220PubMedCrossRef
8.
go back to reference Scoll BJ, Wong YN, Egleston BL et al (2009) Age, tumor size and relative survival of patients with localized renal cell carcinoma: a surveillance, epidemiology and end results analysis. J Urol 181:506–511PubMedCrossRef Scoll BJ, Wong YN, Egleston BL et al (2009) Age, tumor size and relative survival of patients with localized renal cell carcinoma: a surveillance, epidemiology and end results analysis. J Urol 181:506–511PubMedCrossRef
9.
go back to reference Rais-Bahrami S, Guzzo TJ, Jarrett TW, Kavoussi LR, Allaf ME (2009) Incidentally discovered renal masses: oncological and perioperative outcomes in patients with delayed surgical intervention. BJU Int 103:1355–1358PubMedCrossRef Rais-Bahrami S, Guzzo TJ, Jarrett TW, Kavoussi LR, Allaf ME (2009) Incidentally discovered renal masses: oncological and perioperative outcomes in patients with delayed surgical intervention. BJU Int 103:1355–1358PubMedCrossRef
10.
go back to reference Jaffe JS, Ginsberg PC, Gill R, Harkaway RC (2001) A new diagnostic algorithm for the evaluation of microscopic hematuria. Urology 57:889–894PubMedCrossRef Jaffe JS, Ginsberg PC, Gill R, Harkaway RC (2001) A new diagnostic algorithm for the evaluation of microscopic hematuria. Urology 57:889–894PubMedCrossRef
11.
go back to reference Sanchez-Martin FM, Rodriguez FM, Urdaneta-Pignalosa G, Rubio-Briones J, Villavicencio-Mavrich H (2009) Small renal masses: incidental diagnosis, clinical symptoms, and prognostic factors. Adv Urol. 2008:310694. Epub Jan 21 Sanchez-Martin FM, Rodriguez FM, Urdaneta-Pignalosa G, Rubio-Briones J, Villavicencio-Mavrich H (2009) Small renal masses: incidental diagnosis, clinical symptoms, and prognostic factors. Adv Urol. 2008:310694. Epub Jan 21
12.
go back to reference Wolf JS Jr (1998) Evaluation and management of solid and cystic renal masses. J Urol 159:1120–1133PubMedCrossRef Wolf JS Jr (1998) Evaluation and management of solid and cystic renal masses. J Urol 159:1120–1133PubMedCrossRef
13.
go back to reference Hugosson J, Aus G, Becker C et al (2000) Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden. BJU Int 85:1078–1084PubMedCrossRef Hugosson J, Aus G, Becker C et al (2000) Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden. BJU Int 85:1078–1084PubMedCrossRef
Metadata
Title
Urinary ultrasonography in screening incidental renal cell carcinoma: is it obligatory?
Authors
Ahmet Hakan Haliloglu
Omer Gulpinar
Eriz Ozden
Yasar Beduk
Publication date
01-09-2011
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 3/2011
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-010-9843-3

Other articles of this Issue 3/2011

International Urology and Nephrology 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.